Blockchain Registration Transaction Record

hyperCORE International Welcomes ARC to Clinical Trial Network

hyperCORE International expands its global reach by welcoming Applied Research Center of Arkansas to its clinical trial network. Dr. Nathan Livers, CEO of ARC, brings a passion for clinical research and patient care, making the decision to join hyperCORE an easy one.

The inclusion of ARC into hyperCORE's network signifies an expansion of clinical trial capabilities and global reach, potentially leading to groundbreaking advancements in pharmaceutical, medical, and device trials. Dr. Livers' emphasis on patient care and clinical research also indicates a positive impact on the community and potential improvements in healthcare outcomes. Overall, this news highlights the importance of collaboration in advancing clinical research and improving patient care.